Pengda Liu Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Date Time
Cancer Drug Shows Potential Against Pseudo SARS-CoV-2 in Lab Tests
Despite the effectiveness of COVID-19 vaccines, treatments are still needed to combat this disease, which has killed millions of people and still kills thousands each day across the world. Scientists at the UNC School of Medicine conducted lab experiments showing how the cancer drug lenalidomide disrupts a cellular pathway in human cells so that pseudo-viruses derived from SARS-CoV-2 – the virus that causes COVID-19 – cannot enter cells to cause infection.
The research, published in a letter to the journal Signal Transduction and Targeted Therapy, shows the potential of an existing FDA-approved drug to help doctors treat the sickest COVID-19 patients. ....

United States , Siyuan Su , Pengda Liu , Lilly Wong , Guochun Jiang , Ying Wang , Jianfeng Chen , School Of Medicine , Guochun Jiang Lab , Breast Cancer Alliance Young Investigator Grant , Department Of Biochemistry , University Cancer Research Fund , Pengda Liu Lab , Lineberger Comprehensive Cancer Center , Gabrielle Angel Foundation Medical Research Award , Cure Center , V Scholar Research Grant , Signal Transduction , Targeted Therapy , Comprehensive Cancer Center , Angel Foundation Medical Research Award , Cancer Research , Qura Therapeutics , North Carolina , Chapel Hill Center , ஒன்றுபட்டது மாநிலங்களில் ,